Due to the autoimmune etiology of this disorder, IV immunoglobulin (IVIg) or plasma exchange (PE) are the first-line treatments in addition to management of ventilatory failure. IVIg is more ...

Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for HyQvia® ...

Nobile-Orazio and colleagues (2012) compared two of the more commonly used therapies for CIDP: IV immunoglobulin (IVIg) and IV methylprednisolone. The authors performed a multicenter, randomized ...

Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).

The Chinese Medical Association has released new guidelines for diagnosing and treating Mycoplasma pneumoniae in children.

Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...

Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors ...

Intravenous immunoglobulin (IVIG) is a pooled collection of antibodies derived from donors’ plasma. It’s used to treat people with immunodeficiencies to protect them against infection and to ...

Spanish plasma-derived medicines specialist Grifols (MCE: GRF) has announced positive results from its Phase II/III clinical ...